OPK Opko Health Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OPK

Price (delayed)

$1.355

Market cap

$1.01B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.09

Enterprise value

$1.1B

?
Relative Growth: Rel. Growth: 40
Relative Strength: Rel. Strength: 54
Relative Valuation: Rel. Valuation: 31
Relative Profitability: Rel. Profitability: 39

OPKO Health, Inc. (OPKO) is a multi-national pharmaceutical and diagnostics company. OPKO is developing a range of solutions to diagnose, treat and prevent various conditions, including molecular diagnostics tests, point-of-care ...

Highlights
Opko Health's EPS has soared by 67% from the previous quarter and by 61% YoY
The net income has soared by 66% since the previous quarter and by 59% year-on-year
Opko Health's quick ratio has increased by 18% YoY but it has decreased by 10% from the previous quarter
The company's revenue fell by 11% YoY
Opko Health's equity has decreased by 9% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.opko.com
Peers: JNJ ABT REGN ARDX

Key stats

What are the main financial stats of OPK

OPK stock price

How has the Opko Health stock price performed over time
Intraday
2.65%
1 week
9.27%
1 month
-10.86%
1 year
13.87%
YTD
7.54%
QTD
-9.67%

Financial performance

How have Opko Health's revenue and profit performed over time
Revenue
$587.9M
Gross profit
$239.69M
Operating income
-$48.25M
Net income
-$72.89M
Gross margin
40.8%
Net margin
-12.4%
The operating income has soared by 67% YoY and by 52% from the previous quarter
The net income has soared by 66% since the previous quarter and by 59% year-on-year
The net margin has soared by 66% QoQ and by 54% YoY
OPK's operating margin has soared by 63% year-on-year and by 53% since the previous quarter

Price vs fundamentals

How does OPK's price correlate with its fundamentals

Growth

What is Opko Health's growth rate over time

Valuation

What is Opko Health stock price valuation
P/E
N/A
P/B
0.86
P/S
1.74
EV/EBIT
N/A
EV/EBITDA
20.1
EV/Sales
1.88
Opko Health's EPS has soared by 67% from the previous quarter and by 61% YoY
Opko Health's equity has decreased by 9% YoY
The P/B is 7% below the 5-year quarterly average of 0.9 but 5% above the last 4 quarters average of 0.8
The P/S is 21% above the 5-year quarterly average of 1.4
The company's revenue fell by 11% YoY

Efficiency

How efficient is Opko Health business performance
Opko Health's ROS has soared by 73% from the previous quarter but it has decreased by 11% YoY
OPK's ROIC has soared by 71% since the previous quarter but it is down by 13% year-on-year
The ROE has soared by 65% QoQ and by 55% YoY
The ROA has soared by 65% from the previous quarter and by 54% YoY

Dividends

What is OPK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPK.

Financial health

How did Opko Health financials performed over time
The company's total assets is 184% higher than its total liabilities
Opko Health's quick ratio has increased by 18% YoY but it has decreased by 10% from the previous quarter
Opko Health's current ratio has decreased by 7% from the previous quarter
The debt is 67% lower than the equity
The debt to equity is up by 10% year-on-year and by 3.1% since the previous quarter
Opko Health's equity has decreased by 9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.